← SynDRA
PUTRESCINE
SynDRA canonical compound SYN0002367 — structure-anchored drug synonym record
| Clinical phase | Phase 2 |
| Primary target(s) | AMD1 | KCNJ4 | ODC1 |
| Mechanism of action | tissue transglutaminase inhibitor |
All known targets
Mechanisms of action (all sources)
- KCNJ4 ANTAGONIST
- tissue transglutaminase inhibitor
- AMD1 INHIBITOR
- ODC1 INHIBITOR
Cross-references
Synonyms
- NSC-60545
- 1,4-diaminobutane
- 1,4-butanediamine
- butane-1,4-diamine
- tetramethylenediamine
- Butylenediamine
- Putrescin
- 1,4-Butylenediamine
- Tetramethyldiamine
- 1,4-Tetramethylenediamine
- putrescina
- Putreszin
- Tetramethylendiamin
- UNII-V10TVZ52E4
- NSC 60545
- BRN 0605282
- H2N(CH2)4NH2
- CCRIS 6751
- AI3-25444
- 1,4-Diamino-n-butane
- EINECS 203-782-3
- 1,4-Diaminobutane, 99%
- CHEMBL46257
- V10TVZ52E4
- CHEBI:17148
- KIDHWZJUCRJVML-UHFFFAOYSA-N
- MFCD00008235
- 1,4-butanediammonium
- Diaminobutane dihydrochloride
- PUT
- HSDB 7865
- 1,4 Diaminobutane
- 1,4 Butanediamine
- RefChem:177345
- DTXCID2021107
- but-2-ynedinitrile
- Putrescine, free base
- Putrescine; NSC 60545; Putramine
- BUTANE, 1,4-DIAMINO-
Look up PUTRESCINE in the interactive SynDRA portal →